| |

International Journal of Medicinal Mushrooms

Impact factor: 0.576

International Journal of Medicinal Mushrooms
 

Get Adobe Flash player

 

ISSN: 1521-9437 Print

ISSN: 1940-4344 Online

  You can order a single issue or an individual article, as well as view the table of contents or article abstract by clicking on the volume number, then the issue number in the right sidebar.  

Institutional price: $610.00

Online subscription
Add subscription to shopping cart
click 'Save as...' here to save XML metadata   Year 2007, Volume 9 / Issue 2

DOI: 10.1615/IntJMedMushr.v9.i2

Pages: 98

DOI: 10.1615/IntJMedMushr.v9.i2.30 Article price - $35.00 Add to shopping cart

Immunomodulatory and Antitumor Activities of Water-Soluble Proteoglycan Isolated from the Fruiting Bodies of Culinary-Medicinal Oyster Mushroom Pleurotus ostreatus (Jacq.: Fr.) P. Kumm. (Agaricomycetideae)


ABSTRACT

Pleurotus ostreatus, also known as oyster mushroom, is studied for its immunomodulatory and anticancer properties. The present study aimed to find a bioactive proteoglycan from a fruiting body of P. ostreatus that could be used as a biological response modifier for immunomodulatory and anticancer effects with the fewest side effects. A water-soluble fraction of alcohol-precipitated fruiting body extract was purified through anion and cation exchange chromatography, followed by gel filtration (Sephadex G-100) chromatography. The purified proteoglycan fraction was represented by the polysaccharide-to-protein ratio of 3.46. The monosaccharide composition analysis of the proteoglycan showed the presence of galactose, mannose, and glucose in the ratio of 12:11:10. The fraction was examined for its immunomodulatory and anticancer effects in a mouse Sarcoma-180 model. The purified proteoglycan stimulated the growth of thymocytes and splenocytes and induced interleukin-4 and interferon gamma in vitro. It also activated macrophages to produce nitric oxide, super oxide anion, and hydrogen peroxide. The growth inhibition of Sarcoma-180 cells both in vivo and in vitro by this proteoglycan fraction was significant and arrested cell cycle in G0/G1 phase.


pages 123-138


<< Previous article   Next article >>

 

Volume 11, 2009

Volume 10, 2008

Volume 9, 2007

Issue 1

Issue 2

Issue 3&4

Volume 8, 2006

Volume 7, 2005

Volume 6, 2004

Volume 5, 2003

Volume 4, 2002

Volume 3, 2001

Volume 2, 2000

 
begell house, inc.
publishers
50 Cross Highway
Redding, CT 06896
Tel.: (203) 938 1300
Fax: (203) 938 1304